Susquehanna International Group
INAB icon

Susquehanna International Group’s IN8bio INAB Stock Holding History

Susquehanna International Group’s Portfolio INAB Stock Details INAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-827
Closed -$4.12K – 13163
2025
Q1 		$4.12K Buy
+827
New +$6.6K ﹤0.01% 12266

Other funds holding INAB

BCM
BIOS Capital Management Fort Worth, Texas $52.9M AUM 30.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
Alyeska Investment Group
Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Susquehanna International Group's INAB Position: Q2 2025 in Review

Susquehanna International Group sold out of IN8bio (INAB) in Q2 2025, closing a stake of 827 shares — an estimated $4.12K sold.

Susquehanna International Group first reported a position in INAB in Q1 2025 and held it in 1 quarter. The position peaked at $4.12K in Q1 2025. 12 funds tracked by Wall St. Rank hold INAB as of Q2 2025.

  • Susquehanna International Group reported no remaining IN8bio position as of Q2 2025 after selling out during the quarter.
  • Susquehanna International Group sold 827 IN8bio shares in Q2 2025, an estimated $4.12K.
  • Susquehanna International Group first reported a position in IN8bio in Q1 2025 and held it in 1 quarter.
  • Susquehanna International Group's IN8bio position peaked at $4.12K in Q1 2025.
  • 12 funds tracked by Wall St. Rank held IN8bio as of Q2 2025.

Based on Susquehanna International Group's 13F filing for Q2 2025, filed 14 Aug 2025.